A small oxazine compound as an anti-tumor agent : A novel pyranoside mimetic that binds to VEGF, HB-EGF, and TNF-α
スポンサーリンク
概要
- 論文の詳細を見る
A novel pyranoside mimetic compound, DMBO (2-(2,6-difluorophenyl)-4a,5,6,7,8,8a-hexahydro-4a-(4-methoxyphenyl)-4H-benzo[e][1,3]oxazine), was designed and synthesized. The sugar mimicking behavior of DMBO was addressed by its ability to bind several cytokines/growth factors such as tumor necrosis factor (TNF)-α, heparin-binding epidermal growth factor-like growth factor (HB-EGF) and vascular endothelial growth factor (VEGF) involved in cancer progression as detected through novel surface plasmon resonance imaging. In addition, DMBO inhibited the binding of TNF-α to anti-TNF-α antibody in vitro and also the production of TNF-α in vivo. The effect of DMBO on TNF-α was supported by our finding that it inhibited the proliferation of metastatic human ovarian cancer cell line (OVSAHO), which abundantly express TNF-α. High-throughput screening of DMBO showed a significant inhibition of heparanase activity at higher concentrations in vitro. DMBO also affected the heparan-degrading activity of mouse osteosarcoma cell line (LM8G7) in a dose-dependent manner, and showed a prominent inhibitory effect on the metastasis of LM8G7 cells to mouse liver. These responses are associated with the strong inhibition of migration, adhesion, invasion and proliferation of LM8G7 cells and also with the anti-angiogenic activity of DMBO. In addition, DMBO markedly inhibited the ectopic secretion of VEGF by LM8G7 cells, which drives the metastatic potential of LM8G7. Furthermore, the interaction of DMBO with HB-EGF was significantly correlated with inhibition of the proliferation of human ovarian cancer cell line (SKOV-3). These results emphasize that DMBO mimics heparan sulfate structurally and its anti-metastatic activity is likely expressed through binding to multiple factors, which are critical for tumor development and progression.
- Elsevier Irelandの論文
- 2010-11-28
著者
-
Sugahara Kazuyuki
神戸薬科大学 生化
-
Sugahara Kazuyuki
Hokkaido Univ. Sapporo
-
Sugahara Kazuyuki
Dept. Of Biochemistry. Kobe Pharmaceutical University
関連論文
- Involvement of chondroitin sulfate E in the liver tumor focal formation of murine osteosarcoma cells
- Functions of chondroitin sulfate/dermatan sulfate chains in brain development: Critical roles of E and iE disaccharide units recognized by a single chain antibody GD3G7.
- Identification of human hyaluronidase-4 as a novel chondroitin sulfate hydrolase that preferentially cleaves the galactosaminidic linkage in the trisulfated tetrasaccharide sequence
- Isolation and characterization of a novel chondroitin sulfate from squid liver integument rich in N-acetylgalactosamine(4,6-disulfate) and glucuronate(3-sulfate) residues
- Demonstration of the hepatocyte growth factor signaling pathway in the in vitro neuritogenic activity of chondroitin sulfate from ray fish cartilage
- 線虫 Caenorhabditis elegans におけるコンドロチン加水分解酵素
- 多硫酸化コンドロイチン硫酸の構造と機能 : 特有の硫酸化パターンと神経細胞機能調節活性
- Unique heparan sulfate from shrimp heads exhibits a strong inhibitory effect on infections by dengue virus and Japanese encephalitis virus
- Dermatan sulfate epimerase 2 is the predominant isozyme in the formation of the chondroitin sulfate/dermatan sulfate hybrid structure in postnatal developing mouse brain
- Analysis of the structure and neuritogenic activity of chondroitin sulfate/dermatan sulfate hybrid chains from porcine fetal membranes
- A small oxazine compound as an anti-tumor agent : A novel pyranoside mimetic that binds to VEGF, HB-EGF, and TNF-α
- Development of a mouse monoclonal antibody against the chondroitin sulfate-protein linkage region derived from shark cartilage